BRAF and melanoma: This interaction between SIRT3 and glutamine metabolism would be interesting to study in other cancers, such as melanoma, where inhibiting glutamine transport has been considered as a method of suppressing melanoma growth in both wild-type BRAF and BRAF-inhibitor-resistant melanoma [157].